SEARCH THIS WEBSITE
Did you know that certain non-ablative fractional lasers, which target water in the skin, may do more than improve appearance? Emerging research suggests they can remodel the skin’s epigenome, reverse some age-related DNA methylation patterns, and influence genes involved in non-melanoma skin cancer biology. This points to a possible dual benefit of visible rejuvenation and reduced genetic damage.
Key Areas We Will Cover
- How non-ablative fractional lasers that target water work on the skin
- New evidence of epigenetic changes after treatment
- Reversal of age-related DNA methylation patterns
- Possible implications for non-melanoma skin cancer risk
- Clinical improvements seen alongside molecular changes
- What this means for patients considering laser rejuvenation
Introduction
Non-ablative fractional lasers that target water in the skin have long been used to improve texture, tone and signs of photoaging while leaving the outer surface largely intact. A recent split-face pilot study has taken this further by examining changes at the epigenetic level. The results indicate that these treatments may remodel DNA methylation patterns associated with skin aging and modulate activity in genes linked to the development of basal cell and squamous cell carcinomas. This article summarises the findings in accessible language and explains their potential relevance. A Dermatologist can advise whether such treatments suit your skin type and goals.
How Do Non-Ablative Fractional Lasers That Target Water Work?
These lasers deliver energy in a fractional pattern that is preferentially absorbed by water in the skin.
The controlled thermal effect stimulates a wound-healing response and collagen remodelling without removing the full thickness of the epidermis. Clinically this produces gradual improvement in pigmentation, texture and overall appearance. The new research suggests the benefits may extend deeper, to the level of gene regulation through DNA methylation.
What Did the Recent Study Find About the Skin’s Epigenome?
Treatment was associated with progressive and coordinated changes in DNA methylation.
In a split-face pilot study, adults received a series of non-ablative fractional laser treatments on one side of the face. Epidermal samples collected by noninvasive tape stripping showed hundreds of differentially methylated regions one month after treatment. These changes expanded and then stabilised by six months. The affected loci were enriched in pathways related to epidermal differentiation, collagen organisation, wound response and stem-cell maintenance.
Did the Laser Reverse Age-Related Methylation Patterns?
Yes. Age-related methylation trajectories were reversed at the large majority of assessed sites linked to skin aging.
Approximately 84 % of the examined age-associated sites showed an anticorrelated shift after treatment. There was significant enrichment for reversal of age-hypermethylated sites and for remethylation of age-hypomethylated regions. These shifts began at one month and continued through the six-month follow-up, suggesting a rejuvenating effect at the epigenetic level.
Could These Changes Influence Non-Melanoma Skin Cancer Risk?
The study also observed modulated epigenetic activity at genes involved in the development of basal and squamous cell skin cancers.
Changes were noted at keratinocyte-regulating loci linked to these common non-melanoma skin cancers. While the findings are preliminary and come from a small pilot study, they raise the possibility that non-ablative fractional lasers targeting water may help reduce certain forms of genetic damage associated with skin-cancer biology, in addition to their established rejuvenating effects. Larger studies will be needed to confirm any clinical impact on cancer risk.
What Clinical Improvements Were Seen?
Treated skin showed measurable gains in appearance that aligned with the molecular changes.
Improvements included reduced pigmentation (with a reported decrease in brown spots), better texture and higher global aesthetic scores. These visible results progressed alongside the epigenetic shifts, supporting the idea that the molecular remodelling translates into clinically relevant rejuvenation.
What Should Patients Know Before Considering Treatment?
Non-ablative fractional lasers that target water are generally well tolerated, but individual assessment is essential.
Results vary according to skin type, degree of photodamage and the specific treatment protocol. A Dermatologist will evaluate suitability, discuss expected outcomes and aftercare, and determine whether this approach aligns with your goals for both appearance and long-term skin health.
At The Skin Care Network, located at 68-70 Union St, Barnet EN5 4HZ, United Kingdom, our consultant Dermatologists provide personalised advice on laser rejuvenation and skin-cancer risk reduction strategies. Call +44 20 8441 1043 to arrange a consultation.
Conclusion
Emerging evidence indicates that non-ablative fractional lasers which target water can remodel the skin’s epigenome, reverse many age-related DNA methylation patterns, and influence genes involved in non-melanoma skin cancer biology. Alongside proven clinical improvements in pigmentation, texture and overall appearance, these molecular findings suggest a potential dual benefit of rejuvenation and reduced genetic damage. While further research is required, the data offer scientific support for effects that clinicians have observed in practice for years. A Dermatologist can help you weigh the evidence and decide whether treatment is appropriate.
Get Started Today
Interested in non-ablative laser rejuvenation and its possible benefits for skin health? Book a consultation with a Dermatologist at The Skin Care Network to discuss your options and receive tailored advice.
Frequently Asked Questions
This FAQ section answers common questions about non-ablative fractional lasers and the new epigenetic findings, supporting informed decisions with guidance from a Dermatologist.
No. Non-ablative fractional lasers that target water create controlled zones of thermal injury beneath the surface while leaving the outer epidermis largely intact, allowing faster recovery than fully ablative procedures.
The recent pilot study showed modulation of epigenetic activity at genes linked to basal and squamous cell carcinoma development, and reversal of aging-related methylation patterns. This is promising but preliminary; larger clinical studies are needed before firm conclusions about cancer-risk reduction can be drawn.
Protocols vary. The study used a series of three treatments spaced several weeks apart. A Dermatologist will recommend a plan based on your skin and goals.
Epigenetic and clinical improvements were observed to stabilise over six months in the study. Maintenance treatments and ongoing sun protection help sustain benefits, as environmental damage continues to accumulate over time.
Adults with signs of photoaging or those interested in both aesthetic improvement and potential long-term skin-health benefits may be candidates. Suitability depends on skin type, medical history and individual risk factors, which a Dermatologist will assess.
